Elanco Animal Health (ELAN) Invested Capital (2018 - 2026)

Elanco Animal Health (ELAN) has 9 years of Invested Capital data on file, last reported at $73.0 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 65.91% year-over-year to $73.0 million; the trailing twelve-month figure through Mar 2026 stood at $270.0 million (down 21.74% YoY), and the FY2025 full-year result was $74.0 million, up 68.18% from the prior year.
• Invested Capital retreated to $73.0 million in Q1 2026, from $74.0 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $394.0 million in Q3 2022 to a low of $38.0 million in Q4 2023.
• A 5-year average of $120.5 million and a median of $61.0 million in 2022 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital jumped 545.9% in 2022 and slumped 90.21% in 2023, its largest moves.
• Tracing ELAN's Invested Capital over 5 years: stood at $388.0 million in 2022, then tumbled by 90.21% to $38.0 million in 2023, then grew by 15.79% to $44.0 million in 2024, then soared by 68.18% to $74.0 million in 2025, then slipped by 1.35% to $73.0 million in 2026.
• Business Quant data shows ELAN's Invested Capital at $73.0 million in Q1 2026, $74.0 million in Q4 2025, and $62.0 million in Q3 2025.